Search for other papers by Kassia B. Reuters in
Google Scholar
PubMed
Search for other papers by Maria C.O.C. Mamone in
Google Scholar
PubMed
Search for other papers by Elsa S. Ikejiri in
Google Scholar
PubMed
Search for other papers by Cleber P. Camacho in
Google Scholar
PubMed
Search for other papers by Claudia C.D. Nakabashi in
Google Scholar
PubMed
Search for other papers by Carolina C.P.S. Janovsky in
Google Scholar
PubMed
Search for other papers by Ji H. Yang in
Google Scholar
PubMed
Search for other papers by Danielle M. Andreoni in
Google Scholar
PubMed
Santa Casa de São Paulo, São Paulo, Brazil
Search for other papers by Rosalia Padovani in
Google Scholar
PubMed
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Rui M.B. Maciel in
Google Scholar
PubMed
Search for other papers by Felipe A.B. Vanderlei in
Google Scholar
PubMed
Fleury Medicina e Saúde, São Paulo, Brazil
Search for other papers by Rosa P.M. Biscolla in
Google Scholar
PubMed
important to exclude thyroid carcinoma, which occurs in approximately 5–15% of nodules, 95% of which are well-differentiated thyroid carcinoma [ 1 - 6 ]. In Brazil, the current estimated incidence of thyroid cancer is 24 cases per 100,000 inhabitants, and
Search for other papers by Luigi Bartalena in
Google Scholar
PubMed
unfavorable outcome of medical treatment include: (i) a still incomplete understanding of the pathogenesis of GO, which prevents the use of targeted therapies; (ii) the low incidence and prevalence of GO, which makes it difficult to validate new and old
Search for other papers by Min Ji Jeon in
Google Scholar
PubMed
Search for other papers by Won Gu Kim in
Google Scholar
PubMed
Search for other papers by Ki-Wook Chung in
Google Scholar
PubMed
Search for other papers by Jung Hwan Baek in
Google Scholar
PubMed
Search for other papers by Won Bae Kim in
Google Scholar
PubMed
Search for other papers by Young Kee Shong in
Google Scholar
PubMed
Introduction The incidence of thyroid cancer has increased all over the world. The age-standardized incidence of thyroid cancer in Korea has also increased sharply since 2000 and reached 49.1 per 100,000 in 2015 [ 1 ]. It is apparent that the
Search for other papers by Evangelos Karvounis in
Google Scholar
PubMed
Search for other papers by Ioannis Kappas in
Google Scholar
PubMed
Search for other papers by Anna Angelousi in
Google Scholar
PubMed
Search for other papers by Georgios-Marios Makris in
Google Scholar
PubMed
Department of Biological Chemistry, Medical School, National and Kapodistrian University of Athens, Athens, Greece
Search for other papers by Eva Kassi in
Google Scholar
PubMed
the thymus gland. MALT lymphoma of the thyroid gland is rarely reported in the literature as its incidence is significantly lower than that of other organs [ 1 , 2 ]. Compared to diffuse large B-cell lymphoma (DLBCL), MALT lymphoma is less
Search for other papers by Sepehr Torabinejad in
Google Scholar
PubMed
Search for other papers by Caterina Miro in
Google Scholar
PubMed
Search for other papers by Biagio Barone in
Google Scholar
PubMed
Search for other papers by Ciro Imbimbo in
Google Scholar
PubMed
Search for other papers by Felice Crocetto in
Google Scholar
PubMed
CEINGE – Biotecnologie Avanzate Scarl, Naples, Italy
Search for other papers by Monica Dentice in
Google Scholar
PubMed
, owing to primary and secondary resistance to these therapies ( 14 ), the median survival is only around 42 months ( 15 ). In addition to the role of the androgen signaling pathway and other mentioned factors affecting the incidence and progression of
Search for other papers by Berna Evranos Ogmen in
Google Scholar
PubMed
Search for other papers by Cevdet Aydin in
Google Scholar
PubMed
Search for other papers by Ibrahim Kilinc in
Google Scholar
PubMed
Search for other papers by Aysegul Aksoy Altinboga in
Google Scholar
PubMed
Search for other papers by Reyhan Ersoy in
Google Scholar
PubMed
Search for other papers by Bekir Cakir in
Google Scholar
PubMed
/FLUS category exhibited marked variability in both the incidence (0.8–28%) and malignancy rate (6–48%) of resection specimens [ 10 - 14 ]. The AUS/FLUS management options of the current guidelines and those recommended by recent studies include repeat FNAB
Search for other papers by Barbara A. Demeneix in
Google Scholar
PubMed
study [ 6 ] 1,040 mothers were studied along with outcomes in their children at 8 years of age. For ASD the data are sparser, and no full studies have yet appeared, as large samples are required to take into account the lower incidence of the disorder
Search for other papers by Julia Ramalho Amalio da Silva Breder in
Google Scholar
PubMed
Search for other papers by Paulo Alonso Garcia Alves in
Google Scholar
PubMed
Search for other papers by Mario Lucio Araújo in
Google Scholar
PubMed
Search for other papers by Barbara Pires in
Google Scholar
PubMed
Search for other papers by Priscila Valverde in
Google Scholar
PubMed
Search for other papers by Daniel Alves Bulzico in
Google Scholar
PubMed
Search for other papers by Fernanda Andrade Accioly in
Google Scholar
PubMed
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Endocrinology Department, Instituto Nacional do Cancer do Rio de Janeiro, Rio de Janeiro, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
). Recent studies have reported an increased incidence of DTC in children and adolescents ( 1 , 3 ). Girls are responsible for the sharply increased incidence observed during adolescence, with the girl-to-boy ratio varying from 2:1 to 5:1 in this period ( 3
Department of Medicine, Endocrinology Service, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Andrade in
Google Scholar
PubMed
Search for other papers by Danielle Probstner in
Google Scholar
PubMed
Search for other papers by Marcus Decnop in
Google Scholar
PubMed
Search for other papers by Daniel Bulzico in
Google Scholar
PubMed
Search for other papers by Denise Momesso in
Google Scholar
PubMed
Department of Medicine, Endocrinology Service, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Rossana Corbo in
Google Scholar
PubMed
Search for other papers by Mario Vaisman in
Google Scholar
PubMed
Department of Medicine, Endocrinology Service, Hospital Universitário Clementino Fraga Filho, Rio de Janeiro, Brazil
Search for other papers by Fernanda Vaisman in
Google Scholar
PubMed
be affected in up to 70–90% of cases [ 2 , 3 ]. Among differentiated thyroid cancer (DTC), it is the second most frequent site of distant metastases. Incidence may vary from 2 to 13% [ 4 ], influenced by the degree of differentiation and histologic
Institute of Clinical Medicine, University of Oslo, Oslo, Norway
Search for other papers by Else Marie Opsahl in
Google Scholar
PubMed
Department of Pathology, Haukeland University Hospital Bergen, Bergen, Norway
Search for other papers by Lars Andreas Akslen in
Google Scholar
PubMed
Search for other papers by Ellen Schlichting in
Google Scholar
PubMed
Search for other papers by Turid Aas in
Google Scholar
PubMed
Search for other papers by Katrin Brauckhoff in
Google Scholar
PubMed
Search for other papers by Anne Irene Hagen in
Google Scholar
PubMed
Search for other papers by Alf Frimann Rosenlund in
Google Scholar
PubMed
Search for other papers by Eva Sigstad in
Google Scholar
PubMed
Search for other papers by Krystyna K. Grøholt in
Google Scholar
PubMed
Search for other papers by Lovise Mæhle in
Google Scholar
PubMed
Department of Medical Genetics, St. Olavs University Hospital, Trondheim, Norway
Search for other papers by Lars Fredrik Engebretsen in
Google Scholar
PubMed
Search for other papers by Lars H. Jørgensen in
Google Scholar
PubMed
Search for other papers by Jan Erik Varhaug in
Google Scholar
PubMed
Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway
Search for other papers by Trine Bjøro in
Google Scholar
PubMed
, respectively. The average incidence rate was 0.22 per 100,000 person years (1: 456,964 persons per year). It increased from 0.18: 100,000 in the first period to 0.25: 100,000 in the second. Of all of the MTC patients, the RET mutation was found in 37